<DOC>
	<DOCNO>NCT01962402</DOCNO>
	<brief_summary>The purpose study determine whether lorcaserin effective weight reduction patient weight gain result antipsychotic medication .</brief_summary>
	<brief_title>Lorcaserin Weight Loss Management Patients Antipsychotics : A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Weight Gain</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients currently atypical antipsychotic The patient 's BMI great equal 30 kg/m2 OR patient 's BMI great equal 27 kg/m2 presence least one weightrelated comorbidity hypertension , type 2 diabetes mellitus , dyslipidemia , metabolic syndrome , obstructive sleep apnea , degenerative joint disease osteoarthritis . Patient agreeable follow provider schedule appointment week 1 , week 2 , week 4 , week 8 , week 12 week 16 initiation medication . EXCLUSION CRITERIA : Pregnancy woman breastfeed The patient great mild aortic valve regurgitation , moderate great mitral valve regurgitation Known hypersensitivity lorcaserin The patient take another weight loss medication concurrently Dementia Age less 18 great 65 No recent substance abuse within 3 month No suicidal ideation within 3 month Unable give inform consent , unless patient conserve , conservator provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>